A Brief Review on Novel (COVID-19) Corona Virus and Its Management – The Global Pandemic Situation

Authors

  • Dr.SUSHMA MUCHUKOTA Pharm.D,(Ph.D)Assistant Professor,Department of Pharmacy Practice,Gautham college of pharmacy,Affiliated RGUHS, Bangalore,560032,Karnataka.
  • Babu Muchukota M.B.B.S, M.D.,(Designated) Professor, Department of Forensic Medicine, S.V. Medical College,Tirupati, Andhra Pradesh, India
  • E. Bhavya M.Pharm, Ph.D., Associate Professor, School of Pharmaceutical Sciences, VISTAS, Pallavaram, Chennai, Tamil Nadu, India
  • Vivekanandan K. M.Pharm, Ph.D., Associate Professor, Department of Pharmaceutical Sciences, Dr.M.G.R. Educational and Research Institute, Chennai, Tamil Nadu, India.
  • Manjoor Ahamad Syed M.Pharm, Ph.D., Associate Professor, Department of Pharmaceutical Sciences, Dr.M.G.R. Educational and Research Institute, Chennai, Tamil Nadu, India

Abstract

Abstract

COVID -19 is a respiratory disease that is contagious, first detected in china and worldwide spread in December 2019. The novel (new) coronavirus (nCoV) coronavirus disease 2019, or COVID-19 that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome
(SARS-CoV). A novel coronavirus is a new strain that has not been previously identified in humans. Genus Coronaviruses (CoV) belongs to the family Coronaviridae. Health authoritiesare currently referring to it as 2019 Novel Coronavirus (2019-nCov).It infects many species of animals including humans, causing acute and chronic diseases. It spreads more rapidly than SARS. This virus usually affects the respiratory tract of humans. It is associated with symptoms like common cold, pneumonia, and severe acute respiratory syndrome (SARS) and sometimes it can also affect the gut. Most recently, authorities identified a coronavirus outbreak in China that has now reached in other countries.

Keywords: Coronaviridae, Middle East Respiratory Syndrome (MERS-CoV), Novel
Coronavirus, Severe Acute Respiratory Syndrome (SARS-CoV), SARS,

Cite this Article

Sushma Muchukota, Babu Muchukota, E. Bhavya, Vivekanandan K., Manjoor Ahamad Syed. A Brief Review on Novel (COVID-19) Corona Virus and Its Management – The Global Pandemic Situation. Research & Reviews: A Journal of Drug Design & Discovery. 2020; 7(2): 1–7p.

Author Biography

  • Dr.SUSHMA MUCHUKOTA, Pharm.D,(Ph.D)Assistant Professor,Department of Pharmacy Practice,Gautham college of pharmacy,Affiliated RGUHS, Bangalore,560032,Karnataka.

    Pharm.D- Gold medalist

    Persuing (Ph.D)-Department of Pharmaceutical sciences,

    Assistant Professor,Department of Pharmacy Practice,

    Gautham college of pharmacy,Affiliated RGUHS, Bangalore,560032,Karnataka.

    Email- [email protected]

Downloads

Published

2020-09-15

Issue

Vol. 7 No. 2 (2020)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.